The cold, cough, and sore throat remedies market is set to grow to $45.4 Bn by 2026, driven by OTC drugs and self-medication trends.
Future Market Insights’ latest report delivers such discernments that are expected to leave a considerable imprint on the global market for cold, cough & sore throat remedies. Based on the report, the global cold, cough & sore throat remedies market is presently valued at US$ 32.4 Bn, and is anticipated to incur sluggish growth at 3.2% CAGR to bring in just over US$ 45.4 Bn by the end of 2026. The report distinctly indicates that rising adoption of self-medication practices and effective home remedies is restraining the market’s overall growth.
Seeking professional medical help for curing cold, cough or sore throat is become a rare practice, let alone getting admitted in a hospital. Prevalence of cold, cough & sore throat problems through the ages has made people more independent in terms of treating them. In the years to come, effective home remedies will continue to gain traction and people will be taking care of their cold or sore throat through such easy-to-treat remedies.
Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-1292
In the report, titled “Cold, Cough and Sore Throat Remedies Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” affordability of OTC drugs, rising economic burden of respiratory diseases, availability of medications in variable dosages, and fast & instant relief delivered through such cold, cough & sore throat remedies are driving the market’s growth. Nevertheless, the demand for cold, cough & sore throat remedies is less likely to soar at a healthy rate.
Product Recalls & Low Entry of New Players Impacting the Market’s Growth
Firstly, the global cold, cough & sore throat remedies market is projected to witness umpteen product recalls. Global leaders in pharmaceuticals industry such as Novartis AG, Pfizer Inc., Bayer AG, GlaxoSmithKline plc., and Reckitt Benckiser Group plc are key players in the global market for cold, cough & sore throat remedies. Despite, there are several newly-launched products that have been recalled after FDA’s censure. Besides, even consumer goods behemoths such as Procter & Gamble Co. and Johnson & Johnson Services Inc. are partaking in the market’s growth. This has resulted in a lowering entry of emerging drugmakers, which has further distorted the market’s growth. Other leading manufacturers of cold, cough & sore throat remedies include AstraZeneca plc, Prestige Brands Inc., and Sun Pharmaceutical Industries Ltd.
Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-1292
The report highlights how Asia-Pacific excluding Japan (APEJ) region will remain the largest market for cold, cough & sore throat remedies. The region’s proximity to environmental pollution makes its residents more prone to respiratory diseases. With over 30% stake in global revenues, the APEJ cold, cough & sore throat remedies market will global dominate through 2026. North America and Europe will also remain at the forefront, by collectively accounting for nearly half of the global revenues throughout the forecast period.
The report further reveals that in 2017 and beyond, the demand for antihistamine drugs, expectorants and decongestants will remain considerably high as these revenues from sales of these drugs will showcase growth at more than 3% CAGR. Tablets or pills and nasal drops will also dominate as dosage types, accounting for over 40% share of market value through 2026. The report also predicts retail pharmacies & drug stores as the largest distribution channels for cold, cough & sore throat remedies. Together, these channels will bring in nearly US$ 30 Bn by the end of 2026.
Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/1292
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Orthokeratology Market: The global Orthokeratology Market is estimated to reach US$ 58.1 Mn in 2022, and is further projected to be valued at US$ 88.7 Mn by 2028, rising at a CAGR of 7.3% from 2022 to 2028.
Membrane Microfiltration Market: Recent developments in Membrane Microfiltration Market suggest that the industry is slated to generate a value of US$ 5,096.5 Mn in 2022, anticipated to register a positive CAGR of 7.9% in the forecast period 2022-2028 and reach a value of US$ 8,048.5 Mn.
Positron Emission Tomography (PET) Scanners Market: Demand for Positron Emission Tomography (PET) Scanners Market is projected to grow at a steady 5.1% CAGR from 2021 to 2031, reaching US$ 1.2 Bn in 2021.
Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
The article discusses the growth and trends in the cold, cough, and sore throat remedies market, projected to reach $45.4 Bn by 2026.
Self-medication practices and home remedies are restraining growth, while OTC drugs and economic burden of respiratory diseases drive it.
Asia-Pacific excluding Japan, North America, and Europe are leading regions in the market.
Explore more articles in the Research Reports category
